Notizie su ALS

Ultime notizie

Titoli nella lingua originale della fonte.

• BlackRock Group Ceases to Be Substantial Shareholder in ALS Ltd (si apre in una nuova scheda)

  The Globe and Mail · 1 ott 2026

• ALS Limited (ASX:ALQ): FY26 Earnings Growth, Lower Debt and FY27 Priorities (si apre in una nuova scheda)

  Kalkine · 1 ott 2026

• Viral Infections Can Accelerate the Progression of ALS, McMaster Researchers Find | Newswise (si apre in una nuova scheda)

  Newswise · 1 ott 2026

• VectorY broadens global PIONEER-ALS clinical trial cohort (si apre in una nuova scheda)

  Clinical Trials Arena · 30 set 2026

• How HIV Inspired Drug Development for ALS (si apre in una nuova scheda)

  Technology Networks · 30 set 2026

• I AM ALS COMMUNITY POWERS HISTORIC REAUTHORIZATION OF ACT FOR ALS (si apre in una nuova scheda)

  PR Newswire · 29 set 2026

• New AI app helps people with ALS keep their own voices (si apre in una nuova scheda)

  alsnewstoday.com · 29 set 2026

• Tiziana Life Sciences doses first ALS patients in Phase 2a Foralumab trial (si apre in una nuova scheda)

  Proactive financial news · 29 set 2026

• Nasal spray antibody trialled in early-stage ALS patients (si apre in una nuova scheda)

  nrtimes.co.uk · 29 set 2026

• VectorY Expands PIONEER-ALS Phase 1/2 Clinical Trial Size (si apre in una nuova scheda)

  Business Wire · 29 set 2026

• How minerals testing demand is reshaping earnings at S&P/ASX 200 laboratory group ALS Limited (ASX: ALQ) (si apre in una nuova scheda)

  Kalkine · 29 set 2026

• ACT for ALS Reauthorization Advances to the President After Today’s Senate Action (si apre in una nuova scheda)

  mda.org · 28 set 2026

• Robert Earl Keen’s Longtime Guitarist Received an ALS Diagnosis. Texas Music Is Rallying (si apre in una nuova scheda)

  Rolling Stone · 28 set 2026

• NeuroSense CFO to discuss ALS drug PrimeC progr... (si apre in una nuova scheda)

  Pluang · 28 set 2026

• Altius Minerals (TSX:ALS), Why Is It Drawing Fresh Attention? (si apre in una nuova scheda)

  Yahoo Finance · 28 set 2026

• Sola Biosciences Japan Nabs ¥6B Grant to Advance ALS Gene Therapy (si apre in una nuova scheda)

  Genome Web · 28 set 2026

• Tiziana doses first three patients in ALS trial of nasal antibody foralumab (si apre in una nuova scheda)

  Yahoo Finance · 28 set 2026

• Japan AMED grant supports Sola’s SOL-257 for ALS (si apre in una nuova scheda)

  bioworld.com · 28 set 2026

• Tiziana Life Sciences Announces First Participants Dosed in ALS BANYAN Clinical Trial of Intranasal Foralumab (si apre in una nuova scheda)

  The Manila Times · 28 set 2026

• ALS Limited (ASX:ALQ) Operates DRP for Final Dividend With Shares Acquired On Market (si apre in una nuova scheda)

  Kalkine · 28 set 2026

• What Makes ALS (ASX:ALQ) Stand Out in Its Latest Update? (si apre in una nuova scheda)

  kalkinemedia.com · 28 set 2026

• Here's Why We Think ALS (ASX:ALQ) Is Well Worth Watching (si apre in una nuova scheda)

  Simply Wall Street · 27 set 2026

• Former JD executive strives through debilitation to find cure for ALS (si apre in una nuova scheda)

  bastillepost.com · 27 set 2026

• Golf tournament started by father with ALS returns as family legacy (si apre in una nuova scheda)

  Live 5 News · 27 set 2026

• Former JD executive and wife dedicate themselves to ALS research amid setbacks (si apre in una nuova scheda)

  bastillepost.com · 27 set 2026

• '90 Day Fiancé' Star Jenny Slatten's ALS Battle Worsens—And Fans Fear the Worst (si apre in una nuova scheda)

  Complex · 26 set 2026

• Low muscle mass may help predict survival in people with ALS (si apre in una nuova scheda)

  alsnewstoday.com · 25 set 2026

• ‘90 Day Fiancé’ star Jenny Slatten getting ‘weaker by the day’ amid ALS battle (si apre in una nuova scheda)

  pagesix.com · 25 set 2026

• Laughlin Graduates ALS Class 26-F (si apre in una nuova scheda)

  aetc.af.mil · 25 set 2026

• ‘90 Day Fiancé’ Star Jenny Slatten Is ‘Getting Weaker by the Day’ amid ALS Struggle (si apre in una nuova scheda)

  people.com · 24 set 2026